Get the latest Science News and Discoveries

Phase III ARTEMIS-008 trial shows risvutatug rezetecan significantly improves overall survival in relapsed small-cell lung cancer

Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Related news:

Phase III MAVERICK trial supports brain MRI surveillance alone as standard of care for small-cell lung cancer

Phase III TAISHAN-302 trial shows Tam-Peli significantly improves survival in relapsed small-cell lung cancer

Chemotherapy combination boosts overall survival in patients with EGFR-mutant non-small cell lung cancer - EurekAlert!